Skip to main content

EL IMPACTO DEL MICROBIOMA Y DIETA EN LA PROGRAMACION, CRECIMIENTO Y DESARROLLO DE LA SALUD INFANTIL: SEGUIMIENTO 6 AÑOS DE LA COHORTE MAMI

PID2022-139475OB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2022
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The maternal gut microbiome in pregnancy: implications for the developing immune system

  • Koren, Omry
  • Konnikova, Liza
  • Brodin, Petter
  • Mysorekar, Indira U.
  • Collado, María Carmen
The gut microbiome has important roles in host metabolism and immunity, and microbial dysbiosis affects human physiology and health. Maternal immunity and microbial metabolites during pregnancy, microbial transfer during birth, and transfer of immune factors, microorganisms and metabolites via breastfeeding provide critical sources of early-life microbial and immune training, with important consequences for human health. Only a few studies have directly examined the interactions between the gut microbiome and the immune system during pregnancy, and the subsequent effect on offspring development. In this Review, we aim to describe how the maternal microbiome shapes overall pregnancy-associated maternal, fetal and early neonatal immune systems, focusing on the existing evidence and highlighting current gaps to promote further research., O.K. is supported by the European Research Council Consolidator grant (grant agreement no. 101001355). I.U.M. is supported by NIH/NICHD grant R01 HD091218 and 3R01HD091218-04S1(RADx-UP Supplement). O.K. and M.C.C. acknowledge the support by Biostime Institute Nutrition and Care (BINC) grant. L.K. is supported by Yale University pilot funds, Binational Science Foundation (2019075), and the National Institutes of Health (R21TR002639, R21HD102565, R01DK129552 and R01AI171980). P.B. is supported by grants from Knut and Alice Wallenberg Foundation (2019.0181), Svenska sällskapet för Medicinsk forskning, SSMF (CG-22-0148-H-02), the Swedish Research council (2019-01495, 2022-01567), EU Horizon project grant UNDINE (grant agreement: 101057100) and Wellcome Trust Discovery award (226507/Z/22/Z). M.C.C. was supported by a European Research Council Starting grant (grant agreement no. 639226), the Spanish Ministry of Science and Innovation (grant ref. PID2022-139475OB-I00), PROMETEO GVA (ref. 2020/012) and also from the Horizon Europe Program (INITIALISE- 101094099 project)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX 2021-001189-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Role of vertical and horizontal microbial transmission of antimicrobial resistance genes in early life: insights from maternal-infant dyads

  • Bernabeu, Manuel
  • Cabello Yeves, Elena
  • Flores, Eduard
  • Samarra, Anna
  • Kimberley Summers, Joanna
  • Marina, Alberto
  • Collado, María Carmen
Early life represents a critical window for metabolic, cognitive and immune system development, which is influenced by the maternal microbiome as well as the infant gut microbiome. Antibiotic exposure, mode of delivery and breastfeeding practices modulate the gut microbiome and the reservoir of antibiotic resistance genes (ARGs). Vertical and horizontal microbial gene transfer during early life and the mechanisms behind these transfers are being uncovered. In this review, we aim to provide an overview of the current knowledge on the transfer of antibiotic resistance in the mother-infant dyad through vertical and horizontal transmission and to highlight the main gaps and challenges in this area., This work has been supported by PROMETEO GVA (NEOHEALTH ref. 2020/012). The authors acknowledge the comments and suggestions of Dr. Raul Cabrera-Rubio. who thanks the Generalitat-Valenciana for the grant of the Plan GenT project (CDEIGENT 2020). M.B. thanks to the post-PhD grant 'Juan de la Cierva' (ref. JDC2022-050269-I) supported by the Spanish Ministry of Science, Innovation and Universities/State Investigation Agency (MCIU/AEI) and the European Union 'NextGenerationEU'/PRTR. E.C-Y received a FPI predoctoral fellowship from the Spanish Ministry of Science and Innovation with identifier PRE2020-092531. E.F.V thanks to a Predoctoral grant awarded by the Spanish Ministry of Science and Innovation and the European Social Fund Plus (ESF+) for the training of doctors within the framework of the State Plan for Scientific, Technical and Innovation Research 2021–2023 (ref. CEX2021-001189-S-20-1). A.S. acknowledges Generalitat-Valenciana-European Social Fund (ACIF/2021) for the predoctoral fellowship grant. M.C.C. acknowledges the support by the European Research Council Starting grant (MAMI grant ref. 639226), Horizon Europe Program (INITIALISE ref. 101094099), Spanish Ministry of Science and Innovation (MAMI-Plus ref. PID2022-139475OB-I00), by the Joint Action 'European Joint Programming Initiative “A Healthy Diet for a Healthy Life” (JPI-HDHL)' — FOOD-HYPERSENS call (ECOBIOTIC) and the national funding from Programación Conjunta Internacional (PCI) (ref. PCI2021-122059-2A), Spanish Government (Ministry of Science, Innovation and Universities) and also by Biostime Institute Nutrition & Care (BINC) grant. IATA-CSIC authors also acknowledge the Spanish government Ministry of Science and Innovation/State Investigation Agency (MCIN/AEI) to the Center of Excellence Accreditation Severo Ochoa (CEX2021-001189-S/MCIN/AEI/10.13039/501100011033). A.M. acknowledges the support by grants PID2019-108541GB-I00 and PID2022-137201NB-I00 from Spanish Government (Ministry of Science and Innovation). M.C.C. and A.M. are part of the CSIC's Global Health Platform (PTI Salud Global)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Mind the gap regarding the knowledge of infant exposure to mycotoxins, acrylamide, bisphenols and heavy metals through human milk

  • Pallarés, Noelia
  • Ferrer, Emilia
  • Berrada, Houda
  • Barba, Francisco J.
  • Salgado-Ramos, Manuel
  • Collado, María Carmen
Breastfeeding offers infants nutritional, immunological, neurological and emotional benefits, although some toxic compounds can also be detected in human milk and transported along this food chain, such as mycotoxins, bisphenols, heavy metals, and acrylamide. This narrative review collects data from around the world regarding the occurrence of these contaminants in human milk with a view to evaluate infant exposure to these compounds and the potential associated health risks. The factors driving the presence of these toxins in human milk are explored, as are some strategies and measures to minimize their transfer to infants. The incidence and the levels of toxic compounds reported in bibliography vary, ranging from trace levels to considerably high concentrations. The data obtained suggest that breastfed infants better tolerate exposure to toxic compounds than infants fed with milk formulas, even though in some cases the estimated daily intake may exceed the established reference values. Certain measures should be adopted to minimize the exposure of mothers and breastfed infants to toxic compounds, such as monitoring of good practices throughout the food chain and dietary control, avoiding commodities more susceptible to contamination., This preparation of this review was supported by the Spanish Ministry of Science and Innovation project (PID2020-115871RB-I00) and by the Generalitat Valenciana (Spain: projects GV/2020/020 and AICO/2021/037). N.P. was supported by the post-PhD program of the University of Valencia for the requalification of the Spanish University System from the Ministry of Universities of the Government of Spain, modality “Margarita Salas” (MS21-045)”, financed by the European Union, Next Generation EU. M.S–R was supported by the post-PhD program from the Universidad de Castilla-La Mancha and by the Ministry of Universities of the Spanish Government, modality “Margarita Salas - Complementaria” (2023-POST-21234), financed by the European Union, Next Generation EU. Finally, M.C.C. acknowledges the support of The Ramón Areces Foundation (ref. CIVP19A5918) and also, the award of the Spanish government MCIN/AEI to the IATA-CSIC as Center of Excellence Accreditation Severo Ochoa (CEX2021-001189-S/MCIN/AEI/10.13039/501100011033). M.C.C. also acknowledges the support of an H2020-ERC Starting Grant 639226 and that of the Spanish Ministry of Science and Innovation (MCIN) research grant (ref. PID2022-139475OB-I00)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Unlocking the power of human milk and infant feeding: Understanding how nutrition and early microbiota interaction shapes health programming

  • Zhernakova, Alexandra
  • Yassour, Moran
  • Hall, Lindsay J
  • Collado, María Carmen
Human milk represents a highly evolved bioactive system that promotes colonization by infant microbial pioneers, supports immune maturation, and fosters infant development. Beyond providing nutrition, human milk contains key bioactive components, such as microbes, metabolites, human milk oligosaccharides, immunoglobulins, lactoferrin, and antimicrobial peptides. These factors influence colonization of the infant gut microbiome and facilitate immune development and metabolic health, with implications for health outcomes and risk of non-communicable diseases. In this review, we highlight the impact of infant feeding, human milk constituents (especially bioactive compounds), and weaning on infant microbial trajectories. By understanding how early-life nutrition influences microbial colonization and nutrient sensing, i.e., "how we feed our microbes," we can develop targeted interventions and personalized diets to support proper gut maturation and disease prevention from infancy to adulthood, as well as explore the therapeutic potential of human milk bioactives beyond infancy, offering new strategies for disease prevention and treatment., M.C.C. acknowledges support from a H2020-ERC Starting Grant (MAMI-639226 project), the Horizon Europe Program (INITIALISE-101094099 project), a Spanish Ministry of Science and Innovation (MCIN) research grant (MAMI+, ref. PID2022-139475OB-I00), and PROMETEO/GVA (Microglocal ref. CIPROM2023/030). M.C.C. would like to acknowledge the award of the Spanish Government MCIN/AEI to the IATA-CSIC as Center of Excellence Accreditation Severo Ochoa (CEX2021-001189-S/MCIN/AEI/10.13039/501100011033). L.J.H. is supported by a Wellcome Trust Investigator Award (220876/Z/20/Z) and the Biotechnology and Biological Sciences Research Council Institute Strategic Programme Food, Microbiome and Health BB/X011054/1 and its constituent project BBS/E/QU/230001B. A.Z. is supported by Netherlands Organization for Scientific Research (NWO) VICI grant VI.C.232.074, NWO Gravitation grant ExposomeNL 024.004.017, NWO KIC grant KICH1.LWV04.21.01, ZonMW ME/CFS grant 10091012110015, the EU Horizon Europe Program grants INITIALISE (101094099), and DarkMatter (“ID-DarkMatter-NCD” [project number 101136582])., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

An Old Story Back: Human Milk Antibodies' Protective Roles Against Allergy Development

  • Jackson, Courtney M.
  • Collado, María Carmen
  • Dallas, David C.
  • Insel, Richard A.
  • Macpherson, Andrew J.
  • Palmer, Debra J.
  • Seppo, Antti E.
  • Verhasselt, Valerie
  • Järvinen, Kirsi M.
Human milk is a rich source of immunomodulatory factors that influence the development of the infant immune system, including susceptibility to allergic diseases. Among these components, milk antibodies have been extensively studied for their role in protecting against infections; however, their potential contribution to allergy prevention may be equally important. The mechanisms of protection include allergen exclusion, enhanced and targeted antigen presentation, immune modulation via shaping of the infant gut microbiome, and direct regulation of gut immune responses. This review summarizes current evidence on the secretion of human milk antibodies, highlights what is known and what remains unclear about their role in allergy prevention and outlines the need for further research to develop antibody-based strategies for early allergy prevention., his work was supported by H2020-ERC Starting Grant (MAMI, ref. 639226), Horizon Europe Program (INITIALISE, ref. 101094099), the Joint Action ‘European Joint Programming Initiative “A Healthy Diet for a Healthy Life” (JPI-HDHL)’—FOOD-HYPERSENS call (ECOBIOTIC), Programación Conjunta Internacional (PCI) (ref. PCI2021-122059-2A), Spanish Ministry of Science and Innovation (MCIN) research grant (MAMI+, ref. PID2022-139475OB-I00), NIH R01HD109193, R01HD097367 and R01HD106140, Family Larsson Rosenquist Foundation, Stan Perron Charitable Foundation Fellowship, National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Numbers U19AI175113 and U01AI173032., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Human Milk Bioactive Compounds and Allergic- and Infectious-Related Infant Outcomes: A Systematic Review

  • Flores Ventura, Eduard
  • Guseva, Daria
  • Hübert, Vanessa
  • Samarra, Anna
  • Ensenauer, Regina
  • Collado, María Carmen
The impact of Human Milk (HM) bioactive compounds on infant health is crucial yet complex. Current research highlights their role in immune system development and disease prevention. This review aims to synthesize existing literature on the role of HM's bioactive compounds in the onset of diagnosed allergies, immunological diseases, and responses to infectious diseases by infants and children up to 18 years. The systematic review adhered to Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA). A comprehensive search strategy was employed across PubMed, Web of Science, SCOPUS, Scientific Electronic Library Online (SciELO), Cochrane Library, Latin American and Caribbean Health Sciences Literature (LILACS), and LIVIVO. Quality assessment utilized Joanna Briggs Institute checklists for various study designs. Protocol: CRD42023432030. The systematic review encompassed 34 studies, published from 1983 to 2024, representing a total of 9,298 mother-infant dyads. Included studies reported that allergic-related conditions, particularly food allergy, sensitization, and atopic dermatitis, were inversely associated with HM linolenic and linoleic acid. In a meta-analysis of three studies, infants with atopic dermatitis showed lower total omega-3 levels (SMD = -0.46, 95% CI: -1.82 to -0.90, I2 = 91%, p < 0.01), with reduced EPA and DGLA, suggesting, but not confirming, a potential protective role of omega-3 and involvement of inflammatory pathways. Furthermore, results on infectious-related conditions, primarily diarrhoea and Group B Streptococcus (GBS) infections, suggested inverse associations with 2'-fucosyllactose (2´-FL), lacto-N-difucohexaose I (LDFH-I), and immunoglobulins (Anti-GBS secretory immunoglobulin A (SIgA), anti-lipopolysaccharide IgA (Anti-LPS IgA), anti-cholera toxin IgA, respectively). Results of studies on upper and lower respiratory tract infections, otitis media, and dental caries suggested inverse associations with galectins and galectin-3, lacto-N-tetraose (LNT), 2´-FL, and Haemophilus influenzae. Data suggest that HM bioactive compounds, such as polyunsaturated fatty acids (PUFAs), HMOs, and a number of specific immunoglobulin A (IgA) antibodies may influence allergic and infectious outcomes in infants. In pooled analyses of omega-3 levels, HM fed to infants with atopic dermatitis showed reduced EPA and DGLA. However, these pooled estimates are severely limited by high statistical heterogeneity (I2 = 91%) and should be interpreted as exploratory findings. Despite of the limited overall evidence due to heterogeneity, low replication, and methodological variability, this review offers a broad synthesis of current findings and highlights key knowledge gaps, providing a foundation for future research focused on elucidating the immunological roles of understudied components, such as antimicrobial peptides, through multi-omics and longitudinal approaches., E.F.V. was supported by a predoctoral grant awarded by the Spanish Ministry of Science and Innovation and the European Social Fund Plus (ESF+) for doctoral training within the framework of the State Plan for Scientific, Technical and Innovation Research 2021–2023 (ref. CEX2021-001189-S-20-1). E.F.V. and M.C.C. also acknowledge support from the Spanish Ministry of Science and Innovation (MAMI-Plus project, ref. PID2022-139475OB-I00), as well as from the Joint Action, “European Joint Programming Initiative: A Healthy Diet for a Healthy Life” (JPI-HDHL) FOOD-HYPERSENS call (ECOBIOTIC project, ref. MCIN/AEI/10.13039/501100011033 and the European Union ‘NextGenerationEU’/PRTR), and national funding from the Programación Conjunta Internacional (PCI) (ref. PCI2021-122059-2A) of the Spanish Ministry of Science, Innovation and Universities. The IATA-CSIC team acknowledges the award from the Spanish Government (MCIN/AEI) to the Institute of Agrochemistry and Food Technology (IATA-CSIC) as a Centre of Excellence Severo Ochoa (CEX2021-001189-S, MCIN/AEI/10.13039/501100011033), With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S)., Peer reviewed